SPECIMEN SHAREHOLDERS’ AGREEMENTShareholders’ Agreement • April 18th, 2022
Contract Type FiledApril 18th, 2022This Specimen Agreement illustrates the buy-sell arrangement on the critical illness of an individual shareholder of a corporation whereby the healthy shareholder will purchase the shares of the critically ill shareholder.
SPECIMEN SHAREHOLDERS’ AGREEMENTShareholders’ Agreement • March 29th, 2022
Contract Type FiledMarch 29th, 2022This Specimen Agreement illustrates the buy-sell arrangement on the critical illness of an individual shareholder of a corporation whereby the healthy shareholders will purchase the shares of the critically ill shareholder using insurance proceeds received by the healthy shareholders on corporate-owned critical illness insurance.
SPECIMEN SHAREHOLDERS’ AGREEMENTShareholders’ Agreement • March 29th, 2022
Contract Type FiledMarch 29th, 2022This Specimen Agreement illustrates the buy-sell arrangement on the critical illness of an individual shareholder of a corporation whereby the healthy shareholder will purchase the shares of the critically ill shareholder.
SPECIMEN SHAREHOLDERS’ AGREEMENTShareholders’ Agreement • February 1st, 2022
Contract Type FiledFebruary 1st, 2022This Specimen Agreement illustrates the buy-sell arrangement on the critical illness or death of an individual shareholder of a corporation whereby such shareholder’s shares will be purchased by the other shareholder.
SPECIMEN SHAREHOLDERS’ AGREEMENTShareholders’ Agreement • January 28th, 2022
Contract Type FiledJanuary 28th, 2022This Specimen Agreement illustrates the buy-sell arrangement on the critical illness or death of an individual shareholder of a corporation whereby such shareholder’s shares will be purchased by the other shareholder.
SPECIMEN SHAREHOLDERS’ AGREEMENTShareholders’ Agreement • January 28th, 2022
Contract Type FiledJanuary 28th, 2022This Specimen Agreement illustrates the buy-sell arrangement on the critical illness of an individual shareholder of a corporation whereby the healthy shareholders will purchase the shares of the critically ill shareholder using insurance proceeds received by the healthy shareholders on corporate-owned critical illness insurance.